Wilson Sonsini Advises a16z on Talkiatry’s $130 Million Series C

On June 18, 2024, Talkiatry, a leading provider of high-quality, in-network psychiatric care, announced the completion of a $130 million Series C funding. The equity round was led by Andreessen Horowitz (a16z) with participation from Perceptive Advisors. Wilson Sonsini Goodrich & Rosati advised a16z on the transaction.

As a full-stack provider group, Talkiatry employs its own full-time psychiatrists, allowing for more consistency in the quality and cost-effectiveness of care. By integrating physicians directly into their operations, Talkiatry can standardize the quality of care and influence patient outcomes over time. The Series C investment will fuel Talkiatry's continued expansion of its value-based care model for behavioral health as it scales high-quality, in-network care.

The Wilson Sonsini team that advised a16z on the transaction includes:

Corporate
Rezwan Pavri
Colin Conklin
Annie Kim
Estefano Martinez

Regulatory
Andrea Linna
Eva Yin
Hale Melnick

For more information, please see Talkiatry's news release or a16z's blog post. Additional coverage can be found on The Wall Street Journal and Fierce Healthcare.